Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov 2:7:151.
doi: 10.1186/1746-1596-7-151.

Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge

Affiliations

Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge

Somak Roy et al. Diagn Pathol. .

Abstract

Aim: This study attempted to distinguish primary bladder adenocarcinoma (PBA) from metastatic colonic adenocarcinomas (MCA), which is a difficult diagnostic and clinical problem.

Methods: Twenty-four cases of bladder adenocarcinomas (12 primary & 12 metastatic colorectal) were included in the study with urothelial carcinoma (UC) and colonic adenocarcinoma (CA) as controls. A panel of immunohistochemical (IHC) stains along with fluorescence in-situ hybridization (FISH), using the UroVysion probe set, was performed.

Results: The majority of the PBAs presented with advanced disease. Enteric histologic subtype was the most common morphological variant. Strong nuclear with cytoplasmic-membranous staining of β-catenin was seen in 75% of MCA and only 16.7% PBA (<10% staining cells). Although abnormal nuclear staining with E-cadherin was seen in both PBA and MCA, it was more frequent in former. CK-7, CK-20, villin and CDX-2 stains were not helpful in distinguishing the two entities. FISH did not reveal any unique differences in chromosomal abnormality between the two groups.

Conclusion: Although there was a statistically significant difference in β-catenin and E-cadherin staining between two groups, we did not find any IHC or FISH marker that was specific for PBA. Distinction between PBA and MCA remains a diagnostic problem and clinical correlation is vital before rendering a diagnosis.

Virtual slides: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1393156268152357.

PubMed Disclaimer

Figures

Figure 1
Figure 1
a: Primary bladder adenocarcinoma, enteric type. Moderately differentiated malignant glands are seen with dirty luminal necrosis. Elongated, enlarged and hyperchromatic nuclei with prominent stratification line the malignant glands. (Hematoxylin & eosin, x100). b: Primary bladder adenocarcinoma, mucinous type. Scattered small groups of tumor cells with intracytoplasmic mucin are seen in a background of abundant mucinous material (Hematoxylin & eosin, x200). c: Primary bladder adenocarcinoma, signet ring cell type: Tumor comprised of diffuse sheets of signet ring cells infiltrating the bladder wall (Hematoxylin & eosin, x200). d: Cystitis cystica involving the surface urothelium with underlying invasive primary bladder adenocarcinoma (Hematoxylin & eosin, x100). e: Extensive cystitis glandularis, intestinal type seen adjacent to a focus of invasive primary bladder adenocarcinoma (not seen in this image) (Hematoxylin & eosin, x40). f: Metastatic colorectal adenocarcinoma. Moderately differentiated, infiltrating malignant glands with morphological features similar to primary bladder adenocarcinoma see in a (Hematoxylin & eosin, x100).
Figure 2
Figure 2
a: Primary bladder adenocarcinoma. Strong cytoplasmic membranous staining with β-catenin (DAB chromogen, x100). b: Metastatic colorectal adenocarcinoma. Strong nuclear staining in addition to cytoplasmic staining with β-catenin (DAB chromogen, x100). c: Primary bladder adenocarcinoma. Strong nuclear staining with e-cadherin in addition to weaker cytoplasmic staining pattern. This pattern was more frequent in this group of tumor in contrast to metastatic colorectal adenocarcinoma (DAB chromogen x200). d: Metastatic colorectal adenocarcinoma. Prominent cytoplasmic membranous staining with e-cadherin. Note the absence of nuclear staining (DAB chromogen, x200).
Figure 3
Figure 3
a: Primary bladder adenocarcinoma demonstrating apical brush border staining with villin. Very similar staining pattern was also seen in metastatic colorectal adenocarcinoma. (DAB chromogen, x100). b: Primary bladder adenocarcinoma demonstrating strong diffuse nuclear staining with CDX-2. Metastatic colorectal adenocarcinoma demonstrated same staining pattern. (DAB chromogen, x100). c: Primary bladder adenocarcinoma shows strong cytoplasmic staining with CK7. Overall, it was infrequently seen in glandular bladder tumors, however slightly more frequently in primary than metastatic adenocarcinomas. (DAB chromogen, x100). d: Primary bladder adenocarcinoma shows diffuse strong cytoplasmic positivity for CK20. This was also seen in majority of metastatic colorectal adenocarcinoma. (DAB chromogen, x100).
Figure 4
Figure 4
Primary bladder adenocarcinoma. FISH using UroVysion probe set demonstrates complete loss of yellow signal in some cells (homozygous loss 9p21) and single chromosome 3 gain in fewer cells (>2 red signals) (Red – CEP3, Green – CEP7, Aqua – CEP17 and Yellow – LSI 9p21, x600).
Figure 5
Figure 5
Primary bladder adenocarcinoma. FISH using UroVysion probe set demonstrates a polysomy pattern with more than 2 red, green and aqua signals. (Red – CEP3, Green – CEP7, Aqua – CEP17 and Yellow – LSI 9p21, x600).

References

    1. Grignon DJ, Ro JY, Ayala AG, Johnson DE, Ordonez NG. Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases. Cancer. 1991;67:2165–2172. doi: 10.1002/1097-0142(19910415)67:8<2165::AID-CNCR2820670827>3.0.CO;2-M. - DOI - PubMed
    1. Thomas AA, Stephenson AJ, Campbell SC, Jones JS, Hansel DE. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Hum Pathol. 2009;40:108–116. doi: 10.1016/j.humpath.2008.06.022. - DOI - PubMed
    1. Wang HL, Lu DW, Yerian LM, Alsikafi N, Steinberg G, Hart J, Yang XJ. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol. 2001;25:1380–1387. doi: 10.1097/00000478-200111000-00005. - DOI - PubMed
    1. Anderstrom C, Johansson SL, von Schultz L. Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic study. Cancer. 1983;52:1273–1280. doi: 10.1002/1097-0142(19831001)52:7<1273::AID-CNCR2820520724>3.0.CO;2-7. - DOI - PubMed
    1. Jones WA, Gibbons RP, Correa RJ Jr, Cummings KB, Mason JT. Primary adenocarcinoma of bladder. Urology. 1980;15:119–122. doi: 10.1016/0090-4295(80)90400-8. - DOI - PubMed

MeSH terms